Holger Wesche is CSO at Harpoon Therapeutics, Inc. (HARP). They have made 7 open-market trades across 1 company since 2020, most recently 2021-07-01.
CIK 0001763592
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HARP | 62,852 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2021-07-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HARP | SELL | 2021-07-01 | 2021-07-06 | $14.00 | $140K | -8.9% | -26.7% | -45.3% |
| HARP | SELL | 2021-04-01 | 2021-04-05 | $20.45 | $204K | -5.4% | +5.1% | -36.3% |
| HARP | SELL | 2021-01-04 | 2021-01-06 | $18.58 | $314K | +34.2% | +10.7% | +21.4% |
| HARP | SELL | 2020-10-01 | 2020-10-05 | $16.27 | $163K | -6.6% | -7.6% | +12.2% |
| HARP | SELL | 2020-07-01 | 2020-07-02 | $16.20 | $162K | -8.0% | -28.3% | +1.1% |
| HARP | SELL · 10b5-1 | 2020-05-12 | 2020-05-13 | $14.09 | $20K | +79.3% | +27.9% | -0.8% |
| HARP | SELL | 2020-05-07 | 2020-05-11 | $14.12 | $179K | +50.1% | +30.6% | -4.8% |
| HARP | SELL · 10b5-1 | 2020-04-28 | 2020-04-30 | $14.05 | $18K | +15.0% | +49.7% | +0.7% |
| HARP | SELL | 2020-01-02 | 2020-01-06 | $14.40 | $144K | +4.2% | +14.1% | -16.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.